Research map: A Harmonized Visual Reading Framework for Tau PET Staging in Alzheimer Disease

Back to the article

Papers in this map

  1. Neuropathological stageing of Alzheimer-related changes · Heiko Braak · 1991 · 16633 citations · Cited by this paper
  2. Error in Funding/Support · 2026 · Related
  3. 3D Slicer as an image computing platform for the Quantitative Imaging Network · Andriy Fedorov · 2012 · 9319 citations · Cited by this paper
  4. Clinical Characteristics, Neuroimaging Findings, and Mortality in Korsakoff Syndrome · 2026 · Related
  5. Mild cognitive impairment as a diagnostic entity · Ronald Carl Petersen · 2004 · 7975 citations · Cited by this paper
  6. Intravenous Immunoglobulin Add-On in Newly Diagnosed Idiopathic Inflammatory Myopathies · 2026 · Related
  7. Neuropathological Alterations in Alzheimer Disease · Alberto Serrano‐Pozo · 2011 · 3448 citations · Cited by this paper
  8. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China · 2025 · Related
  9. Donanemab in Early Symptomatic Alzheimer Disease · John Randall Sims · 2023 · 2897 citations · Cited by this paper
  10. Exhaled Carbon Monoxide Levels May Offer Clues on the Etiology of Parkinson Disease · 2026 · Related
  11. Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup · Clifford R. Jack · 2024 · 2682 citations · Cited by this paper
  12. Cerebral Amyloid Angiopathy–Like Brain Imaging and Dural Arteriovenous Fistula · 2026 · Related
  13. The Centiloid Project: Standardizing quantitative amyloid plaque estimation by PET · William E. Klunk · 2014 · 1406 citations · Cited by this paper
  14. Unprecedented In Vivo MRI Resolution of Basal Ganglia at 11.7 T · 2026 · Related
  15. PET Imaging of Tau Deposition in the Aging Human Brain · Michael Schöll · 2016 · 1288 citations · Cited by this paper
  16. When to Use the HINTS Examination in Patients With Dizziness · 2026 · Related
  17. Biomarkers for neurodegenerative diseases · Oskar Hansson · 2021 · 1179 citations · Cited by this paper
  18. Administrative Bloat in Neurology and Academic Medicine · 2026 · Related
  19. Version 3 of the Alzheimer Disease Centers’ Neuropsychological Test Battery in the Uniform Data Set (UDS) · Sandra Weıntraub · 2017 · 697 citations · Cited by this paper
  20. Portable Low-Field MRI of the Brain in Clinic and Community Settings · 2026 · Related
  21. Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia · Gil D. Rabinovici · 2019 · 690 citations · Cited by this paper
  22. Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline · Rik Ossenkoppele · 2022 · 520 citations · Cited by this paper
  23. Discriminative Accuracy of [ 18 F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders · Rik Ossenkoppele · 2018 · 502 citations · Cited by this paper
  24. Positron Emission Tomography Imaging With [ 18 F]flortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes · Adam Fleisher · 2020 · 463 citations · Cited by this paper
  25. Biomarker modeling of Alzheimer’s disease using PET-based Braak staging · Joseph Therriault · 2022 · 323 citations · Cited by this paper
  26. Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders · Antoine Leuzy · 2020 · 248 citations · Cited by this paper
  27. Tau‐positron emission tomography correlates with neuropathology findings · Val J. Lowe · 2019 · 216 citations · Cited by this paper
  28. In vivo quantification of neurofibrillary tangles with [18F]MK-6240 · Tharick Ali Pascoal · 2018 · 200 citations · Cited by this paper
  29. Biomarker-based staging of Alzheimer disease: rationale and clinical applications · Joseph Therriault · 2024 · 197 citations · Cited by this paper
  30. Autoradiography validation of novel tau PET tracer [F-18]-MK-6240 on human postmortem brain tissue · Cinthya Agüero · 2019 · 177 citations · Cited by this paper
  31. Effect of Off-Target Binding on 18F-Flortaucipir Variability in Healthy Controls Across the Life Span · Suzanne L. Baker · 2019 · 133 citations · Cited by this paper
  32. CerebrA, registration and manual label correction of Mindboggle-101 atlas for MNI-ICBM152 template · Ana Laura Manera · 2020 · 125 citations · Cited by this paper
  33. [F‐18]AV‐1451 positron emission tomography retention in choroid plexus: More than “off‐target” binding · Miloš D. Ikonomović · 2016 · 83 citations · Cited by this paper
  34. Updated Appropriate Use Criteria for Amyloid and Tau PET: A Report from the Alzheimer’s Association and Society for Nuclear Medicine and Molecular Imaging Workgroup · Gil D. Rabinovici · 2025 · 68 citations · Cited by this paper
  35. Frequency and Clinical Outcomes Associated With Tau Positron Emission Tomography Positivity · Alexis Moscoso · 2025 · 63 citations · Cited by this paper
  36. Head-to-head comparison of [18F]-Flortaucipir, [18F]-MK-6240 and [18F]-PI-2620 postmortem binding across the spectrum of neurodegenerative diseases · Cinthya Agüero · 2024 · 58 citations · Cited by this paper
  37. Insights into the use of biomarkers in clinical trials in Alzheimer's disease · Tharick Ali Pascoal · 2024 · 53 citations · Cited by this paper
  38. Tau PET positivity in individuals with and without cognitive impairment varies with age, amyloid-β status, APOE genotype and sex · Rik Ossenkoppele · 2025 · 52 citations · Cited by this paper
  39. Evaluation of a visual interpretation method for tau‐PET with 18 F‐flortaucipir · Ida Sonni · 2020 · 44 citations · Cited by this paper

Source: OpenAlex (CC0)